A detailed history of Dn B Asset Management As transactions in Repligen Corp stock. As of the latest transaction made, Dn B Asset Management As holds 8,220 shares of RGEN stock, worth $1.18 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,220
Previous 8,220 -0.0%
Holding current value
$1.18 Million
Previous $1.51 Million 31.44%
% of portfolio
0.01%
Previous 0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024

BUY
$170.78 - $208.42 $1.4 Million - $1.71 Million
8,220 New
8,220 $1.51 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.98B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Dn B Asset Management As Portfolio

Follow Dn B Asset Management As and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dn B Asset Management As, based on Form 13F filings with the SEC.

News

Stay updated on Dn B Asset Management As with notifications on news.